Persistent apparent pancreatic β-cell defects in premenarchal pcos relatives

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 10, 2014, Pages 3855-3862

  Torchen, Laura C ^a   Fogel, Naomi R ^a   Brickman, Wendy J ^a   Paparodis, Rodis ^c   Dunaif, Andrea ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; GLUCOSE; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; ANDROGEN; GLUCOSE BLOOD LEVEL; INSULIN; LIPID; SEX HORMONE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISPOSITION INDEX; DYSGLYCEMIA; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; FOLLOW UP; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID COMPOSITION; MENARCHE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET BETA CELL; PANCREAS ISLET DISEASE; RISK FACTOR; SCHOOL CHILD; SEX HORMONE DETERMINATION; BLOOD; FAMILY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LONGITUDINAL STUDY; METABOLISM; OVARY; PHYSIOLOGY; PROSPECTIVE STUDY; PUBERTY; RISK ASSESSMENT; SECRETION (PROCESS);

ANDROGENS; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 2; FAMILY; FEMALE; GLUCOSE TOLERANCE TEST; GONADAL STEROID HORMONES; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPIDS; LONGITUDINAL STUDIES; OVARY; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; PUBERTY; RISK ASSESSMENT;

EID: 84907609911     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1474     Document Type: Article

References (40)

1. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33:981-1030.
2. Dumesic DA, Abbott DH, Padmanabhan V. Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord. 2007;8:127-141.
3. Shi Y, Zhao H, Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012;44:1020-1025.
4. Chen ZJ, Zhao H, He L, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011;43:55-59.
5. Maliqueo M, Sir-Petermann T, Perez V, et al R. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94:3282-3288.
6. Sir-Petermann T, Maliqueo M, Codner E, et al. Early metabolic derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92:4637-4642.
7. Raissouni N, Kolesnikov A, Purushothaman R, et al. Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome. Int J Pediatr Endocrinol. 2012;2012:14.
8. Trottier A, Battista MC, Geller DH, et al. Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome. Fertil Steril. 2012;98:1627-1634.
9. Sir-Petermann T, Codner E, Maliqueo M, et al. Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:3105-3109.
10. Sir-Petermann T, Codner E, Perez V, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94:1923-1930.
11. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007;92:405-413.
12. Hucking K, Watanabe RM, Stefanovski D, Bergman RN. OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself. Obesity (Silver Spring). 2008;16:1938-1945.
13. Vesper HW, Bhasin S, Wang C, et al. Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods. Steroids. 2009;74:498-503.
14. Levine RJ, Genel M, Cuttler L, Becker DJ, Nieman L, Rosenfield RL. Overcoming burdens in the regulation of clinical research in children. Proceedings of a consensus conference, in historical context. Int J Pediatr Endocrinol. 2011;2011:19.
15. Legro RS, Driscoll D, Strauss JF 3rd, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA. 1998;95:14956-14960.
16. McCartney CR, Blank SK, Prendergast KA, et al. Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls. J Clin Endocrinol Metab. 2007;92:430-436.
17. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(suppl 1):S62-S69.
18. Sam S, Sung YA, Legro RS, Dunaif A. Evidence for pancreatic β-cell dysfunction in brothers of women with polycystic ovary syndrome. Metabolism. 2008;57:84-89.
19. Lee S, Janssen I, Ross R. Interindividual variation in abdominal subcutaneous and visceral adipose tissue: influence of measurement site. J Appl Physiol (1985). 2004;97:948-954.
20. McCartney CR, Prendergast KA, Chhabra S, et al. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J Clin Endocrinol Metab. 2006;91:1714-1722.
21. Liese AD, Bortsov A, Gunther AL, et al. Association of DASH diet with cardiovascular risk factors in youth with diabetes mellitus: the SEARCH for Diabetes in Youth study. Circulation. 2011;123:1410-1417.
22. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666-3672.
23. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev. 1985;6:45-86.
24. Potretzke AM, Schmitz KH, Jensen MD. Preventing overestimation of pixels in computed tomography assessment of visceral fat. Obes Res. 2004;12:1698-1701.
25. Lorenzo C, Wagenknecht LE, Rewers MJ, et al. Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care. 2010;33:2098-2103.
26. Arslanian SA, Saad R, Lewy V, Danadian K, Janosky J. Hyperinsulinemia in African-American children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes. 2002;51:3014-3019.
27. Hannon TS, Bacha F, Lin Y, Arslanian SA. Hyperinsulinemia in African-American adolescents compared with their American white peers despite similar insulin sensitivity: a reflection of upregulated β-cell function? Diabetes Care. 2008;31:1445-1447.
28. Bergman RN, Finegood DT, Kahn SE. The evolution of β-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest. 2002;32(suppl 3):35-45.
29. Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 1989;38:1512-1527.
30. De Fronzo RA, Ferrannini E. Influence of plasma glucose and insulin concentration on plasma glucose clearance in man. Diabetes. 1982;31:683-688.
31. Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes. 1997;46:701-710.
32. Biyasheva A, Legro RS, Dunaif A, Urbanek M. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J Clin Endocrinol Metab. 2009;94:2617-2625.
33. Park JH, Stoffers DA, Nicholls RD, Simmons RA. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest. 2008;118:2316-2324.
34. Arslanian SA, Bacha F, Saad R, Gungor N. Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth. Diabetes Care. 2005;28:115-119.
35. Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab. 2001;86:66-71.
36. Burns SF, Bacha F, Lee SJ, Tfayli H, Gungor N, Arslanian SA. Declining β-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth. Diabetes Care. 2011;34:2033-2040.
37. Willemsen RH, de Kort SW, van der Kaay DC, Hokken-Koelega AC. Independent effects of prematurity on metabolic and cardiovascular risk factors in short small-for-gestational-age children. J Clin Endocrinol Metab. 2008;93:452-458.
38. Kent SC, Gnatuk CL, Kunselman AR, Demers LM, Lee PA, Legro RS. Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab. 2008;93:1662-1669.
39. Arslanian S, Suprasongsin C. Differences in the in vivo insulin secretion and sensitivity of healthy black versus white adolescents. J Pediatr. 1996;129:440-443.
40. Kahn SE, Utzschneider KM. What's next for diabetes prevention? Diabetes Care. 2011;34:1678-1680.